Nina De Moor

2PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 21, 2025
Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report.

Sam Plessers, Jeroen Mebis, Nina De Moor

|Dec 09, 2022
The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients.

Anna C H Willemsen, Nina De Moor, Jeroen Van Dessel

Pageof 1

Frequent Collaborators

1 joint publications

Anna C H Willemsen

1 joint publications

Jeroen Van Dessel

1 joint publications

Laura W J Baijens

1 joint publications

Michel Bila